The Negatives of Real-World Shipping Studies for the Biopharma Cold Chain
Executive Summary: There’s a time and a place for Real-World Shipping studies, but when...
read Details
Regenerative medicine is a novel biomolecular approach to exciting new clinical therapies. Generally, this grouping involves three major therapy applications: cell therapies or stem cell injections; immunotherapy, and tissue engineering. Existing supply chains were never intended to effectively manage an elevated risk profile for a drug that targets a single patient.
Learn how the cold chain validation landscape for regenerative medicines is rapidly changing because:
Executive Summary: There’s a time and a place for Real-World Shipping studies, but when...
read DetailsOn July 22nd, 2022, ISTA released PCG-03: Performance Qualification (PQ) and Performance Verification (PV)...
read DetailsWith this guide, you’ll gain valuable insights into best practices for outsourcing the management...
read Details